Forbes February 21, 2024
The FDA has granted accelerated approval to a new type of cellular therapy for use in people who have skin cancer which has spread to other parts of the body.
“This is a major advance for patients with metastatic melanoma,” said Daniel Olson, MD, medical oncologist at the University of Chicago Cancer Center, which is one of the locations offering the therapy. “Currently, our available therapies can offer control or cure for just over 50% of patients with advanced melanoma, leaving many patients without adequate treatment options,” added Dr. Olson.
The cell-based treatment is known as a “tumor infiltrating lymphocyte” (TIL) therapy and it’s production is a complex several step process started by extracting immune cells from a patient’s tumor...
Today's Sponsors
Today's Sponsor